Company intelligence / Profile preview

Orbit Discovery

Oxford, Oxfordshire, United Kingdomorbitdiscovery.com ↗

Ownership: Private
Employees: ~32
Development stage: Preclinical

Overview

Orbit Discovery has demonstrated the ability to identify high-affinity functional peptides against challenging targets such as GPCRs, soluble proteins for degradation, nucleic acids, and tumor antigens. Their technology enables rapid hit identification with high specificity using large combinatorial libraries. No clinical results have been published; the focus remains on early-stage discovery partnerships.

Therapeutic areas: OtherOncology
Modalities: PeptidesPeptidomimeticsSmall moleculeBioconjugates
Industry: Biotech

Partnerships

Notable partnerships are with pharmaceutical companies and academic researchers for custom discovery projects. Specific partners are not named in public sources.

Beyond the preview

Go deeper on Orbit Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbit Discovery.

Explore the full profile